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PARACRINE REGULATION 01' SPERMATOGENESIS BY GROWTH FACTORS
A.Wahab, M . P a r v i n e n * , a n d O . S o d e r , Pediatric E n d o c r i n ol o g y U n i t , K a r o l i n s k a H o s p i t a l ( L 5 ) , 5 -1 0 4 0 1 S t o c k h o l m , S w e d e n , a n d * D e p a r t m e n t o f A n a t o m y , U n i v e r s i t y o f T u r k u , SF-20520 T u r k u , F i n l a n d .
We
h a v e e s t a b l i s h e d a t e s t i s t i s s u e c u l t u r e m o d e l w h i c h e n a b l e s s t u d i e s o f t h e e f f e c t s o f g r o w t h f a c t o r s
o n g e r m c e l l p r o l i f e r a t i o n i n v i t r o . S e g m e n t s o f s e m i n i f e r o u s t u b u l e s o f a d u l t r a t t e s t e s r e p r e s e n t i n g d e f i n e d s t a g e s o f t h e s e m i n i f e r o u s e p i t h e l i a l c y c l e w i t h r e p r e s e n t a t i v e p r e m i t o t i c a n d p r e m e i o t i c g e r m c e l l s w e r e i d e n t i f i e d b y t r a n s i l l u m i n a t i o n a n d p r e p a r e d b y m i c r o d i s s e c t i o n . T h e t u b u l e s e g m e n t s w e r e i n c u b a t e d a t 3 4 O a n d 37OC f o r 2 4 , 4 8 , a n d 7 2 h w i t h a n d w i t h o u t g r o w t h f a c t o r s a n d t h e DNA s y n t h e s i s w a s d e t e r m i n e d a t t h e e n d o f t h e i n c u b a t i o n . R e c o m b i n a n t e p i d e r m a l g r o w t h f a c t o r (EGF) w a s f o u n d t o s t i m u l a t e p r e m e i o t i c DNA s y n t h e s i s i n a d o s e -d e p e n d e n t f a s h i o n w h e r e a s p r e m i t o t i c DNA synthesis w a s o n l y s l i g h t l y a f f e c t e d . T h i s i n d i c a t e s t h a t EGF i s m a i n l y a m e i t o t i c g r o w t h f a c t o r d u r i n g s p e r m a t o g e n e s i s . T o g e t h e r w i t h p r e v i o u s r e s u l t s d e m o n s t r a t i n g s p e c l f i c e f f e c t s o f i n t e r l e u k i n -l a , n e r v e g r o w t h f a c t o r a n d i n s u l l n -l i k e g r o w t h f a c t o r s , t h e p r e s e n t f i n d l n g f o r m t h e b a s i s o f a h y p o t h e s i s t h a t m i t o t i c a n d m e i o t i c p r o l i f e r a t i o n o f g e r m c e l l s i s d i f f e r e n t i a l l y r e g u l a t e d b y l o c a l l y p r o d u c e d g r o w t h f a c t o r s a c t i n g i n a p a r a c r i n e f a s h i o n . Ten p a t l e n t s with anorchla wpre t r e a t e d wlth t e s t o s t e r o n e undecanoate (40 o r 80mgId) s t a r t l n g a t t h e mean age of 1 1 . 5 years (range: 10 -14 y e a r s ) . The e f f e c t on Tanner s t a g e development, growth v e l o c l t y and weight g a l n a r e presented. Therapy was s t a r t e d wlth 40mg 3x/week (n= 4 ) , 40mg 7xlweek (n=G), and was Increased t o 80mg 7x/week (n=9). Therapy was continued f o r 23.7 months (range: 14 -40 months). S t r e t c h e d p e n l l e l e n g t h before therapy was x = 3.35cm (range: 2.5 -4cm), a t t h e end of therapy 6.25cm on average (range: 5 -8cm). Publc h a i r Tanner s t a g e 2 (PH2) was achieved a f t e r 6.7 months (range: 4 -14 months) PH3 a f t e r 20 months (range: 12 -29 months). Growth v e l o c l t y i n c r e ased t o 6.7cmlyear (range: 3 -'9cmlyear) I n t h e f i r s t year of t r e a tment, concomitant weight g a l n was 7.2kg (range: 5 . 2 -10kg). No s l d e e f f e c t s of treatment were observed. We conclude t h a t o r a l t e s t o s t erone undecanoate therapy s t a r t l n g a t t h e age of 11 years wlth 40mg/d f o r one year and BOmg/d f o r a second year 1 s slrnple, s a f e and e f f e ct l v e and provides f o r a g e n t l e Induction of puberty I n anorchld boys.
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GONADALFUNCTION AFTERFRACTIONATEDTOTAL BODY IRRADIATION (TBI) W El-Ahlary. AL Ogilvy-Stuan', DJ Clark, MDC Donaldson, SM Shalet'. Hospital for Sick Children Glasgow, and Christie Hospital, Manchester', UK.
Gonadal function was asyessed in 28 chtldren (12 male) treated with fractionated TB1 (1200-1440 cGy) after cond~tionlng cytotoxic chemotherapy (cyclophosphamide In=26] or rnelphalan [n=2]). All had received prolonged cytotoxic chemotherapy before TBI 3 hoys had received direct teslicular irradiation (6M)-IW cGy). Gonadal function was assessed hy measurement of basal sex steroids levels and the gonadotrophin response to GnRH. Leydig cell function was assessed hy the testosterone (T) response to an intramuscular injection of HCG (1000 units). All 5 girls who were pubenal at the time of TBI developed ovarian failure ( t gonadotrophins, L. oestradiol, exaggerated gonadotrophin responses to GnRH).
The older prepubenal girls had t hasal gonadotrophins +I-exaggerated gonadotrophin responses to GnRH. All other prepubenal girls had normal prepuhenal gonadotrophin levels. Unlike children who have received large radtat~nn doses to the thorax, breast agenesis was not seen after induction of pubeny with exogenous oestrogdn. All boys were prepuhenal at the time of TBI and five puhenal at assessment. Only one boy (prepuhenal) had a normal T response to HCG. All 3 hoys who had had direct testicular irradiation had abnormal T responses to HCG and elevated gonadotrophins. All other prepubenal boys had normal basal and stimulated gonadotrophin levels, hut suboptimal T response to HCG. All puhennl hoys at assessment hrd elevated gonadotrophins and suhnptimal T response to HCG. Both boys in lale pubeny however had normal hasal T levels. Testicular \,olumes were inappropriately small for pubenal stage. In conclusion the incidence of gonadal dysfunction is high after tiactionared TBI. Ovarian failure is very common in the girls and severe ddrnage to the germinal epithelium in hoys is universal. Leydig cell damage is almost universal but the extent is often subtle. An HCG test can he helpful in determ~ning the need for androgen replacement therapy which is difficult to predict Adequate glucucort~co~d and ~iiincralocortico~d treatment is one of the prerequisltes for normal growth In chiliiren with 21-h).droxylase deficiency. Objectives To evaluate the effects of hydrocortisone dose, sex, salt-wast~ng status, and qualtty of treatnient on short-term grot\'th, and to compare adult lie~ght to target height. Methods: 569 growth episodes of 4-12 rno duration were analysed In 90 patienls (feniales n=56; salt-wasting forni n=12) with regard to height velocity SDS (HVSDS), bone age, and I~ydrocort~so~ie dose 37 ptients had reached adult height. Quality of treatment d u r~i i g each e p~s o d e \\(as rated ivith the lielp of a score using cl~nrcal, laboratory and rad~ological crllerla Ilesulls: In girls iv~tli thesalt-wast~ng varlety (SbV) a n e p t i v e correlat~on of HVSDS lor bone ngc (IIVSDS,,) i\,~th hydrocortisone dose was found (I= -0 41,p<O 006) I f ep~sodes u~~l l i a HVSDS for chronological age (I-IVSDS,,) o u t s~d e tlie range of -2 -12 were ekcluded, nied~an daily hydrocort~sone dose used 11, males (females) was 20.9 (20 6) mg/ni2/d F~nal height (rn+SD) In grrls (156.5k7.1 crn) and boys (169.2k10.0 cni) w . 1 5 91-100.1% and 82 3-100% of target lie~glit with a trend towards taller adult he~ghts in simple v i r~l~z~n g (SV) boys (90 3% vs. 96.5'/~, p<0.055). Stepwise multiple regression revealed an effect of quality of treatment on HVSDS In both prepiiberbl (p<0.0014) and pubertal (p<O0016) subjects, and a nilnor effect of the salt-wasting status on I IVSDS,, only in prepubertals (p<O 012). Conclusions: Although very high hydrocortisone doses were avoided tn our patients, their mean aclult height reaches only tlie 3. percetitile of the normal populat~on Besides treatment qual~ty and salt-wasting status there may be yet unknown factors involved 111 grou,th regt~l.ition of 21-liydroxylase defic~ency pnttents. In order to evaluate adrenarche in female patients with CAH, plasma concentrations of dehydroepimdrosterone sulfate (DEIEAS) were determined (by a specific RIA) longuudinally from 4 to 11 years of age in 16 CAH children in good clinical ' and biochemical control, prebenting with e~ilier a severe classical f o m~ (group A; n = 10) or a non classical form (group B; n = 6). In group A, treatment was staned at 5 f 3.5 days of life lhydroconisone ~nitially 40 f 5 mg/rn2, spill in 3 d a l y doses, lowered to 20 + 5 mg/m2 as soon as a good control was obtuned; fludroconisone 37.5 pgJ1n2 per day initially, then at maintenance dose of 25 pg/m2/dayl. Therapy was staned at a mean age of 5.7 f 0.9 years in group B [hydroconisone 15 i 5 m u m 2 in 3 daily doses]. Results (in nmoVL) are given as mean f SD in table 1. In group A, DH.4S levels were very low at any age, lower th;m m controls but also lower than in group B.
In the Imer. Dl-1AS levels were initially very high for age, then decreased slowly under uearment. In both groups there was no significant rise of DIIEAS afier ape 7-9. Table 1 . < 6 vears 6-7 vears 7-9 vetus 9-1 1 w l r s In conclusion : 1) Despite good clinical and biochemical control ui these 16 selected patients treated with conventional therapy, a physiological adrenarche didn't occur whatever the age of the onset of d~e d i s e .~. 2). The lack of adrenarche is not due to a decreaqed capacity to synthesize DHAS, since its levels were very high in untreated girls wlth non classical CAH. 3). The mechanism by which DtIEAS secretion is inrpaired under substituuve therapy at physiological dose is still not well understood. In 13 unrelated CAH families (2 with 2 patients) from Berlin, Germany, the CYP?IB gene and its region were studied to establish if d~e incidence of each generic lesion and the rel:~tionship between genotype and phenotype are similar to these of other popul:~t~ons. Among our families, 6 had SW, 5 SV and 2 NC form. 26 different CAI-I h;~plotypes have been analyzed using the simple strategy combining Southem blotting studies and specific mplification of the CYP2lB gene by PCR as previously described (Endocn Soc 1991, ubsrr. 1379). To-dare screening for 8 point mutations (PM) of the CYP2lB gene was done. The most common lesions were large delertons (6R6,23%) and two PM: 668-13C-G (6R6, 23%) and 1172N (5/26,20%). Less frequent were large gene converstons (2R6, 8%) and PM G318X (1/26, 4%) and V281L (2R6, 8 6 ) On 15% (4R6) of the haplotypes, no mutation could be found yet. A good correlttr~on exists between genotype and phenotype. All patients homozygous or double heterozygous for large deletions, gehe conversions or G318X had a SW form. 1172N was correlated with SV form ill homozygous as well as in double hetero~ygous patienu. V281L was: found in 1 patient with NC form. In contrast. 668-I3C-G mutation did not correlate well wrth clinical expression: two homozygous oatlents for 668-13C-G had neonatal SW crisis. but acruallv. endocme invesriealion form in german population, was found with different genetic lesions and all phenotypes in our patients. Almost all farnil~es (11113) were fully informative for prenatal d~agnosis when determining the PM in association with our Southem appproach; the 2 remaining ones (ISV, INC) were semi-informative. This direct
